MoneyWorks4Me

Zim Laboratories - Quaterly Results

01 Nov 2023 Evaluate
The sales declined to Rs. 852.60 millions for the September 2023 quarter as compared to Rs. 992.64 millions during the corresponding quarter last year.The Net Profit of the company registered a slight decline of -26.15% to Rs. 41.77  millions from Rs. 56.56 millions.The company reported a degrowth in operating Profit to 103.83 millions from 135.59 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 852.60 992.64 -14.11 1522.67 1917.67 -20.60 3965.31 3294.94 20.35
Other Income 14.21 14.38 -1.18 20.53 33.11 -37.99 64.31 45.06 42.72
PBIDT 103.83 135.59 -23.42 155.54 268.11 -41.99 576.20 424.40 35.77
Interest 12.17 13.58 -10.38 29.51 26.89 9.74 55.75 83.06 -32.88
PBDT 91.66 122.01 -24.88 126.03 241.22 -47.75 520.45 341.34 52.47
Depreciation 37.17 40.43 -8.06 73.77 79.94 -7.72 161.28 148.37 8.70
PBT 54.49 81.58 -33.21 52.26 161.28 -67.60 359.17 192.97 86.13
TAX 12.72 25.02 -49.16 11.92 48.30 -75.32 109.09 62.84 73.60
Deferred Tax 4.53 10.11 -55.19 3.73 20.06 -81.41 46.30 28.84 60.54
PAT 41.77 56.56 -26.15 40.34 112.98 -64.29 250.08 130.13 92.18
Equity 487.26 162.42 200.00 487.26 162.42 200.00 487.26 162.42 200.00
PBIDTM(%) 12.18 13.66 -10.85 10.21 13.98 -26.94 14.53 12.88 12.81
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..